User menu

Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice

Bibliographic reference Todoroff, Julie ; Lemaire, Muriel ; Fillee, Catherine ; Jurion, Fabienne ; Renauld, Jean-Christophe ; et. al. Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice. In: PLoS One, Vol. 8, no. 5, p. e63344 [1-12] (2013)
Permanent URL
  1. World Health Organization (2010) Tuberculosis - Fact sheet n°104.
  2. Roche Paul W, Triccas James A, Winter Nathalie, BCG vaccination against tuberculosis: past disappointments and future hopes, 10.1016/s0966-842x(00)88986-6
  3. World Health Organization (2006) The Stop TB Strategy.
  4. Stop TB Partnership (2009) Tuberculosis vaccine candidates.
  5. Scriba Thomas J., Tameris Michele, Mansoor Nazma, Smit Erica, van der Merwe Linda, Mauff Katya, Hughes E.Jane, Moyo Sizulu, Brittain Nathaniel, Lawrie Alison, Mulenga Humphrey, de Kock Marwou, Gelderbloem Sebastian, Veldsman Ashley, Hatherill Mark, Geldenhuys Hendrik, Hill Adrian V.S., Hussey Gregory D., Mahomed Hassan, Hanekom Willem A., McShane Helen, Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated Infants, 10.1093/infdis/jir195
  6. Elamin Ayssar A., Stehr Matthias, Oehlmann Wulf, Singh Mahavir, The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis: Development of a novel assay and quantification of glycolipid-status of the mycobacterial cell wall, 10.1016/j.mimet.2009.10.010
  7. Romano Marta, Huygen Kris, An update on vaccines for tuberculosis – there is more to it than just waning of BCG efficacy with time, 10.1517/14712598.2012.721768
  8. Lu Dongmei, Hickey Anthony J, Pulmonary vaccine delivery, 10.1586/14760584.6.2.213
  9. Holt Patrick G., Strickland Deborah H., Wikström Matthew E., Jahnsen Frode L., Regulation of immunological homeostasis in the respiratory tract, 10.1038/nri2236
  10. Minne Antoine, Louahed Jamila, Mehauden Sybille, Baras Benoît, Renauld Jean-Christophe, Vanbever Rita, The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response, 10.1111/j.1365-2567.2007.02641.x
  11. Todoroff Julie, Ucakar Bernard, Inglese Malory, Vandermarliere Sophie, Fillee Catherine, Renauld Jean-Christophe, Huygen Kris, Vanbever Rita, Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery, 10.1016/j.ejpb.2012.11.020
  12. Baldridge J, Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration, 10.1016/s0264-410x(99)00572-1
  13. Fingerut E., Gutter B., Goldway M., Eliahoo D., Pitcovski J., B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination, 10.1016/j.vetimm.2006.03.005
  14. Krieg Arthur M, Immune effects and mechanisms of action of CpG motifs, 10.1016/s0264-410x(00)00249-8
  15. Fischer Geferson, Conceição Fabricio R., Leite Fábio P. L., Moraes Carina M., Ferreira Lílian N., Vilela Camila O., Caetano Clarissa F., Vargas Gilberto D., Hübner Sílvia O., Vidor Telmo, Roehe Paulo M., Recombinant Escherichia coli heat-labile enterotoxin B subunit humoral adjuvant effect depends on dose and administration route, 10.1007/s11274-009-0195-z
  16. Mata-Haro V., Cekic C., Martin M., Chilton P. M., Casella C. R., Mitchell T. C., The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4, 10.1126/science.1138963
  17. Krieg Arthur M., Therapeutic potential of Toll-like receptor 9 activation, 10.1038/nrd2059
  18. da Hora Vanusa P., Conceição Fabricio R., Dellagostin Odir A., Doolan Denise L., Non-toxic derivatives of LT as potent adjuvants, 10.1016/j.vaccine.2010.11.091
  19. Barry Mazin, Cooper Curtis, Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy, 10.1517/14712598.7.11.1731
  20. Casella C. R., Mitchell T. C., Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant, 10.1007/s00018-008-8228-6
  21. Stephenson I., Zambon M. C., Rudin A., Colegate A., Podda A., Bugarini R., del Giudice G., Minutello A., Bonnington S., Holmgren J., Mills K. H. G., Nicholson K. G., Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers, 10.1128/jvi.80.10.4962-4970.2006
  22. Gartner Tatiana, Baeten Martijn, Otieno Samuel, Revets Hilde, De Baetselier Patrick, Huygen Kris, Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A, 10.1016/j.imlet.2007.04.010
  23. D'Souza S., Rosseels V., Romano M., Tanghe A., Denis O., Jurion F., Castiglione N., Vanonckelen A., Palfliet K., Huygen K., Mapping of Murine Th1 Helper T-Cell Epitopes of Mycolyl Transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis, 10.1128/iai.71.1.483-493.2003
  24. Grubhofer N., An adjuvant formulation based on N-acetylglucosaminyl-N-acetylmuramyl-l-alanyl-d-isoglutamine with dimethyldioctadecylammonium chloride and zinc-l-proline complex as synergists, 10.1016/0165-2478(94)00188-w
  25. VA Snewin, Infect Immun, 67, 4586 (1999)
  26. Romano Marta, Roupie Virginie, Wang Xiao M., Denis Olivier, Jurion Fabienne, Adnet Pierre-Yves, Laali Rachid, Huygen Kris, Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3, 10.1111/j.1365-2567.2006.02373.x
  27. Cooper Andrea M, Torrado Egidio, Protection versus pathology in tuberculosis: recent insights, 10.1016/j.coi.2012.04.008
  28. Nicod LaurentP., Pulmonary Defence Mechanisms, 10.1159/000029329
  29. Drent M., Cobben N.A.M., Henderson R.F., Wouters E.F.M., van Dieijen-Visser M., Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation, 10.1183/09031936.96.09081736
  30. WH Boom, Infect Agents Dis, 5, 73 (1996)
  31. Ottenhoff Tom H.M., New pathways of protective and pathological host defense to mycobacteria, 10.1016/j.tim.2012.06.002
  32. Santosuosso M., Zhang X., McCormick S., Wang J., Hitt M., Xing Z., Mechanisms of Mucosal and Parenteral Tuberculosis Vaccinations: Adenoviral-Based Mucosal Immunization Preferentially Elicits Sustained Accumulation of Immune Protective CD4 and CD8 T Cells within the Airway Lumen, 10.4049/jimmunol.174.12.7986
  33. Lemaire M. M., Dumoutier L., Warnier G., Uyttenhove C., Van Snick J., de Heusch M., Stevens M., Renauld J.-C., Dual TCR Expression Biases Lung Inflammation in DO11.10 Transgenic Mice and Promotes Neutrophilia via Microbiota-Induced Th17 Differentiation, 10.4049/jimmunol.1101720
  34. Wang Jun, Thorson Lisa, Stokes Richard W., Santosuosso Michael, Huygen Kris, Zganiacz Anna, Hitt Mary, Xing Zhou, Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis, 10.4049/jimmunol.173.10.6357
  35. Goonetilleke N. P., McShane H., Hannan C. M., Anderson R. J., Brookes R. H., Hill A. V. S., Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guerin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara, 10.4049/jimmunol.171.3.1602
  36. Garcia-Contreras L., Wong Y.-L., Muttil P., Padilla D., Sadoff J., DeRousse J., Germishuizen W. A., Goonesekera S., Elbert K., Bloom B. R., Miller R., Fourie P. B., Hickey A., Edwards D., Immunization by a bacterial aerosol, 10.1073/pnas.0800043105
  37. Dietrich J., Andersen C., Rappuoli R., Doherty T. M., Jensen C. G., Andersen P., Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guerin Immunity, 10.4049/jimmunol.177.9.6353
  38. Jeyanathan M., Mu J., Kugathasan K., Zhang X., Damjanovic D., Small C., Divangahi M., Petrof B. J., Hogaboam C. M., Xing Z., Airway Delivery of Soluble Mycobacterial Antigens Restores Protective Mucosal Immunity by Single Intramuscular Plasmid DNA Tuberculosis Vaccination: Role of Proinflammatory Signals in the Lung, 10.4049/jimmunol.181.8.5618
  39. Santosuosso M., McCormick S., Roediger E., Zhang X., Zganiacz A., Lichty B. D., Xing Z., Mucosal Luminal Manipulation of T Cell Geography Switches on Protective Efficacy by Otherwise Ineffective Parenteral Genetic Immunization, 10.4049/jimmunol.178.4.2387
  40. Banaiee N., Kincaid E. Z., Buchwald U., Jacobs W. R., Ernst J. D., Potent Inhibition of Macrophage Responses to IFN-  by Live Virulent Mycobacterium tuberculosis Is Independent of Mature Mycobacterial Lipoproteins but Dependent on TLR2, 10.4049/jimmunol.176.5.3019
  41. Sundaramurthy Varadharajan, Pieters Jean, Interactions of pathogenic mycobacteria with host macrophages, 10.1016/j.micinf.2007.09.007
  42. Lewis David J. M., Huo Zhiming, Barnett Susan, Kromann Ingrid, Giemza Rafaela, Galiza Eva, Woodrow Maria, Thierry-Carstensen Birgit, Andersen Peter, Novicki Deborah, Del Giudice Giuseppe, Rappuoli Rino, Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin, 10.1371/journal.pone.0006999